Detalhe da pesquisa
1.
Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization.
Cell
; 178(4): 1004-1015.e14, 2019 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31398326
2.
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus.
Sci Transl Med
; 14(668): eabq0991, 2022 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36288283
3.
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.
Viruses
; 13(11)2021 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34835131
4.
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
Sci Rep
; 10(1): 16030, 2020 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32994446
5.
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.
Sci Rep
; 8(1): 5939, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29651117
6.
A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca2+ signaling via CD38/ADP-ribosyl cyclase, a putative intracellular NAD+ sensor.
FASEB J
; 16(3): 302-14, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11874980
7.
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.
Proc Natl Acad Sci U S A
; 99(10): 6955-60, 2002 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-12011454